SCHEMBL10575332

SCHEMBL10575332

COc1cc(SC)ccc1-c1nc2cc(C(C)(C)CNS(C)(=O)=O)ccc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ AMY1A P0DUB6 7/20 0.34
▸ PDE5A O76074 1/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ NR1I2 O75469 3/20 0.33
▸ BRD4 O60885 1/20 0.31
▸ PDE2A O00408 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10575337 0.93 AMY1A (0.37) NPC1RAB9AHSP90AA1PKMAMY1A
SCHEMBL10577387 0.87 CDK4 (0.39) NPC1RAB9AAMY1APDE5APDE3B
SCHEMBL10577353 0.86 NPC1 (0.37) NPC1RAB9AHSP90AA1PKMAMY1A
SCHEMBL10695066 0.85 NPC1 (0.40) NPC1RAB9AHSP90AA1PKMAMY1A
SCHEMBL10578728 0.84 NR1I2 (0.34) AMY1APDE5APDE3BPDE3ANR1I2
SCHEMBL10576332 0.84 AMY1A (0.38) NPC1RAB9AHSP90AA1PKMAMY1A
SCHEMBL10577395 0.80 CDK4 (0.45) AMY1A
SCHEMBL10761771 0.79 AMY1A (0.41) NPC1RAB9AHSP90AA1PKMAMY1A
SCHEMBL10575328 0.79 AMY1A (0.41) AMY1ANR1I2BRD4
SCHEMBL10572968 0.79 NPC1 (0.35) NPC1RAB9AHSP90AA1PKMAMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback